Schnieders Capital Management LLC Boosts Stake in CVS Health Corp (NYSE:CVS)

Schnieders Capital Management LLC lifted its holdings in CVS Health Corp (NYSE:CVS) by 35.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,435 shares of the pharmacy operator’s stock after buying an additional 2,735 shares during the quarter. Schnieders Capital Management LLC’s holdings in CVS Health were worth $569,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Bay Harbor Wealth Management LLC boosted its position in CVS Health by 1,871.4% during the first quarter. Bay Harbor Wealth Management LLC now owns 552 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 524 shares in the last quarter. Centaurus Financial Inc. boosted its position in CVS Health by 570.8% during the first quarter. Centaurus Financial Inc. now owns 1,630 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,387 shares in the last quarter. Manchester Financial Inc. purchased a new stake in CVS Health during the second quarter worth $31,000. Hudock Capital Group LLC boosted its position in CVS Health by 54.0% during the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 202 shares in the last quarter. Finally, Executive Wealth Management LLC boosted its position in CVS Health by 62.4% during the second quarter. Executive Wealth Management LLC now owns 565 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 217 shares in the last quarter. Hedge funds and other institutional investors own 75.20% of the company’s stock.

A number of analysts have commented on CVS shares. Standpoint Research upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 5th. Mizuho set a $71.00 target price on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, June 5th. BMO Capital Markets set a $63.00 price target on CVS Health and gave the stock a “hold” rating in a report on Friday, May 3rd. Cantor Fitzgerald reissued a “buy” rating and issued a $80.00 price target on shares of CVS Health in a report on Wednesday, May 1st. Finally, Credit Suisse Group cut CVS Health from an “outperform” rating to a “neutral” rating and cut their price target for the stock from $73.00 to $61.00 in a report on Monday, April 29th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company. CVS Health currently has an average rating of “Buy” and a consensus price target of $75.14.

Shares of NYSE CVS traded down $1.81 during trading on Friday, reaching $60.24. The company had a trading volume of 7,757,375 shares, compared to its average volume of 9,409,576. The stock has a market capitalization of $80.70 billion, a PE ratio of 8.51, a price-to-earnings-growth ratio of 1.36 and a beta of 0.90. The stock has a 50-day moving average price of $57.32 and a two-hundred day moving average price of $56.33. CVS Health Corp has a twelve month low of $51.72 and a twelve month high of $82.15. The company has a current ratio of 0.95, a quick ratio of 0.64 and a debt-to-equity ratio of 1.39.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.70 by $0.19. The firm had revenue of $63.43 billion during the quarter, compared to analyst estimates of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The business’s quarterly revenue was up 35.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.69 earnings per share. On average, sell-side analysts predict that CVS Health Corp will post 6.96 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 2nd. Investors of record on Thursday, July 25th were paid a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, July 24th. This represents a $2.00 annualized dividend and a yield of 3.32%. CVS Health’s payout ratio is currently 28.25%.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

See Also: What is a Stop Order?

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.